A Proof of concept trial of LPCN-1144
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2019
At a glance
- Drugs LPCN-1144 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Acronyms Liver Fat Study
- 17 Jan 2019 According to a Lipocine media release, sixteen-week results from the study are expected later this quarter.
- 17 Jan 2019 Eight-week top-line interim results presented in a Lipocine media release.
- 05 Nov 2018 According to a Lipocine media release, results from this trial are expected in the first quarter of 2019.